Back

Cell type-specific intracellular protein delivery with inactivated botulinum toxin

Roh, H.; Dorner, B. G.; Ting, A. Y.

2023-03-04 biochemistry
10.1101/2023.03.03.531050 bioRxiv
Show abstract

The ability to deliver proteins and peptides across the plasma membrane into the cytosol of living mammalian cells would be highly impactful for both basic science and medicine. Natural cell-penetrating protein toxins have shown promise as protein delivery platforms but existing approaches are limited by immunogenicity, lack of cell type specificity, or their multicomponent nature. Here we explore inactivated botulinum toxin (BoNT) as a protein delivery platform. Using split luciferase reconstitution in the cytosol as a readout for endosomal escape and cytosolic delivery, we showed that BoNT chimeras with nanobodies replacing their natural receptor binding domain could be selectively targeted to cells expressing nanobody-matched surface markers. We used chimeric BoNTs to deliver a range of cargo from 1.3-55 kD, and demonstrated selective delivery of orthogonal cargoes to distinct cell populations within a heterogenous mixture. These explorations suggest that BoNT can be a versatile platform for targeted protein and peptide delivery into mammalian cells.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.